Cargando…

Elevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients

Sickle cell disease (SCD) is an inherited blood disorder that can result in vasculopathy and end organ damage. Angiogenesis has been implicated as a key contributing factor to vascular mediated tissue injury in SCD. The relative plasma levels of angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), and va...

Descripción completa

Detalles Bibliográficos
Autores principales: Antwi-Boasiako, Charles, Frimpong, Emmanuel, Gyan, Ben, Kyei-Baafour, Eric, Sey, Fredericka, Dzudzor, Bartholomew, Abdul-Rahman, Mubarak, Dankwah, Gifty B., Otu, Kate H., Ndanu, Tom A., Campbell, Andrew D., Ekem, Ivy, Donkor, Eric S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164085/
https://www.ncbi.nlm.nih.gov/pubmed/29954157
http://dx.doi.org/10.3390/medsci6030053
_version_ 1783359516163702784
author Antwi-Boasiako, Charles
Frimpong, Emmanuel
Gyan, Ben
Kyei-Baafour, Eric
Sey, Fredericka
Dzudzor, Bartholomew
Abdul-Rahman, Mubarak
Dankwah, Gifty B.
Otu, Kate H.
Ndanu, Tom A.
Campbell, Andrew D.
Ekem, Ivy
Donkor, Eric S.
author_facet Antwi-Boasiako, Charles
Frimpong, Emmanuel
Gyan, Ben
Kyei-Baafour, Eric
Sey, Fredericka
Dzudzor, Bartholomew
Abdul-Rahman, Mubarak
Dankwah, Gifty B.
Otu, Kate H.
Ndanu, Tom A.
Campbell, Andrew D.
Ekem, Ivy
Donkor, Eric S.
author_sort Antwi-Boasiako, Charles
collection PubMed
description Sickle cell disease (SCD) is an inherited blood disorder that can result in vasculopathy and end organ damage. Angiogenesis has been implicated as a key contributing factor to vascular mediated tissue injury in SCD. The relative plasma levels of angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), and vascular endothelial growth factor (VEGF) greatly influence angiogenesis. Dysregulation of these growth factors, leading to a pro-angiogenic state in SCD patients, has been documented in the developed world but there is very little data in Africa. There is the need, therefore, for studies in Ghanaian SCD patients. The aim of this study was to assess plasma levels of Ang-1, Ang-2, and VEGF in homozygous (HbSS) SCD patients with or without complications and healthy controls (HbAA) in Ghana. The study was a case-control study involving 544 participants: 396 HbSS SCD patients and 148 HbAA healthy controls. The study was conducted at the Center for Clinical Genetics (Sickle Cell Clinic) and Accra Area Blood Centre for National Blood transfusion at the Korle-Bu Teaching Hospital, Accra, Ghana. The plasma levels of Ang-1, Ang-2, and VEGF of study participants were measured with a double sandwich enzyme-linked immunosorbent assay (ELISA) technique. Complete blood count (CBC) was measured with an autoanalyser. The mean plasma Ang-1, Ang-2, and VEGF were significantly higher in HbSS SCD patients with or without complications than healthy controls (p < 0.001). The Ang-2/Ang-1 ratio was significantly lower in the controls than the HbSS patients (p < 0.001). The Ang-2/Ang-1 ratio was higher in the HbSS patients with leg ulcers as compared with patients with other complications and healthy controls (p < 0.001). There were higher leucocyte counts in HbSS patients than healthy controls. Overall, there was elevated plasma levels of Ang-1, Ang-2, and VEGF in SCD patients. The higher Ang-2/Ang-1 plasma levels in patients with leg ulcers suggests a possible ongoing angiogenesis and response to inflammatory stimuli. The study provides a first report on plasma levels of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factors in homozygous sickle cell disease patients in Ghana.
format Online
Article
Text
id pubmed-6164085
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61640852018-10-10 Elevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients Antwi-Boasiako, Charles Frimpong, Emmanuel Gyan, Ben Kyei-Baafour, Eric Sey, Fredericka Dzudzor, Bartholomew Abdul-Rahman, Mubarak Dankwah, Gifty B. Otu, Kate H. Ndanu, Tom A. Campbell, Andrew D. Ekem, Ivy Donkor, Eric S. Med Sci (Basel) Article Sickle cell disease (SCD) is an inherited blood disorder that can result in vasculopathy and end organ damage. Angiogenesis has been implicated as a key contributing factor to vascular mediated tissue injury in SCD. The relative plasma levels of angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), and vascular endothelial growth factor (VEGF) greatly influence angiogenesis. Dysregulation of these growth factors, leading to a pro-angiogenic state in SCD patients, has been documented in the developed world but there is very little data in Africa. There is the need, therefore, for studies in Ghanaian SCD patients. The aim of this study was to assess plasma levels of Ang-1, Ang-2, and VEGF in homozygous (HbSS) SCD patients with or without complications and healthy controls (HbAA) in Ghana. The study was a case-control study involving 544 participants: 396 HbSS SCD patients and 148 HbAA healthy controls. The study was conducted at the Center for Clinical Genetics (Sickle Cell Clinic) and Accra Area Blood Centre for National Blood transfusion at the Korle-Bu Teaching Hospital, Accra, Ghana. The plasma levels of Ang-1, Ang-2, and VEGF of study participants were measured with a double sandwich enzyme-linked immunosorbent assay (ELISA) technique. Complete blood count (CBC) was measured with an autoanalyser. The mean plasma Ang-1, Ang-2, and VEGF were significantly higher in HbSS SCD patients with or without complications than healthy controls (p < 0.001). The Ang-2/Ang-1 ratio was significantly lower in the controls than the HbSS patients (p < 0.001). The Ang-2/Ang-1 ratio was higher in the HbSS patients with leg ulcers as compared with patients with other complications and healthy controls (p < 0.001). There were higher leucocyte counts in HbSS patients than healthy controls. Overall, there was elevated plasma levels of Ang-1, Ang-2, and VEGF in SCD patients. The higher Ang-2/Ang-1 plasma levels in patients with leg ulcers suggests a possible ongoing angiogenesis and response to inflammatory stimuli. The study provides a first report on plasma levels of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factors in homozygous sickle cell disease patients in Ghana. MDPI 2018-06-27 /pmc/articles/PMC6164085/ /pubmed/29954157 http://dx.doi.org/10.3390/medsci6030053 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Antwi-Boasiako, Charles
Frimpong, Emmanuel
Gyan, Ben
Kyei-Baafour, Eric
Sey, Fredericka
Dzudzor, Bartholomew
Abdul-Rahman, Mubarak
Dankwah, Gifty B.
Otu, Kate H.
Ndanu, Tom A.
Campbell, Andrew D.
Ekem, Ivy
Donkor, Eric S.
Elevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients
title Elevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients
title_full Elevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients
title_fullStr Elevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients
title_full_unstemmed Elevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients
title_short Elevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients
title_sort elevated proangiogenic markers are associated with vascular complications within ghanaian sickle cell disease patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164085/
https://www.ncbi.nlm.nih.gov/pubmed/29954157
http://dx.doi.org/10.3390/medsci6030053
work_keys_str_mv AT antwiboasiakocharles elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients
AT frimpongemmanuel elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients
AT gyanben elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients
AT kyeibaafoureric elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients
AT seyfredericka elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients
AT dzudzorbartholomew elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients
AT abdulrahmanmubarak elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients
AT dankwahgiftyb elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients
AT otukateh elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients
AT ndanutoma elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients
AT campbellandrewd elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients
AT ekemivy elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients
AT donkorerics elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients